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S U M M A R Y
Meningitis due to Mycoplasma hominis in adults is rarely described, with only three cases having been
reported to date. A case of fatal meningitis in a 39-year-old patient after a neurosurgical procedure for a
subarachnoid haemorrhage is reported herein. Identiﬁcation and treatment were signiﬁcantly delayed
because of the rarity of the aetiology and difﬁculty identifying this organism with the routinely used
conventional methods, such as Gram staining and agar growth on standard agar plates. Clinical
procedures and the treatment of ‘culture-negative’ central nervous system infections is a real challenge
for clinical microbiologists and clinicians, and M. hominis has to be considered as a potential, although
very uncommon, pathogen.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Mycoplasma hominis is a well-known bacterium colonizing the
genito-urinary tract, especially in sexually active adolescent
females. Extragenital infections are rare. To date, only 16 cases
of central nervous system (CNS) infection caused by M. hominis
have been described since 1950 (Table 1).1–15 A new case of
meningitis caused by this bacterium in an adult, following a
neurosurgical procedure, is reported here.
2. Case report
A 39-year-old man with a history of untreated hypertension,
chronic alcoholism, and active smoking was admitted to the
emergency department after a loss of consciousness linked to a
history of a fall. Injuries included a subarachnoid haemorrhage
(Fisher grade III) due to a ruptured pericallosal left artery aneurism,
which was embolized when diagnosed. An external ventricular* Corresponding author. Tel.: +33 2 31 06 33 27; fax: +33 2 31 06 45 73.
E-mail address: isnard-c@chu-caen.fr (C. Isnard).
http://dx.doi.org/10.1016/j.ijid.2016.05.015
1201-9712/ 2016 The Author(s). Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).drain (EVD) was placed and suprapubic catheterization was also
performed. On transfer to the intensive care unit (ICU), the patient
was initially afebrile. Neurological and respiratory failure occurred
1 week later (day 8) and the patient required tracheal intubation.
Antibiotherapy consisting of piperacillin–tazobactam plus line-
zolid was given for 3 days, and this was then switched to
ceftriaxone plus linezolid due to a suspicion of nosocomial
pneumonia. The pneumonia was conﬁrmed by culture of the
Combicath, which harboured 104 CFU/ml Streptococcus
pneumoniae. Computed tomography (CT) perfusion imaging
revealed a peri-aneurysmal haematoma and spasms of the anterior
cerebral arteries (ACA) and right middle cerebral artery (MCA),
without surgical indication. Arteriography conﬁrmed a severe
vasospasm of the bilateral ACA an MCA, and endovascular therapy
with milrinone and nimodipine was started.
Between days 8 and 12, several febrile episodes occurred
despite the antibiotics prescribed for the suspected pneumonia.
Multiple cerebrospinal ﬂuid (CSF) samples (days 8, 10, 11, and 12)
were analyzed and returned sterile. A cell count was not performed
because of the haemorrhagic nature of the samples; direct
examination was also negative. On day 13, in view of this
presentation of aseptic meningitis, the patient was started onciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Cases of CNS infection caused by Mycoplasma hominis in adults reported in the literature1–15
Case Age (years)/sex Sample Diagnosis Diagnosis technique(s) Author, year
1 20/M Abscess PT brain abscess Culture Paine et al., 1950
2 29/M Abscess PO brain abscess Culture Payan et al., 1981
3 76/M CSF PO meningitis Culture McMahon et al., 1990
4 18/F CSF PO meningitis Culture Cohen and Kubak, 1997
5 22/F Abscess PP brain abscess ELISA Zheng et al., 1997
6 40/F Abscess Brain abscess 16S rDNA
Culture
House et al., 2003
7 17/F CSF, blood PP brain abscess Culture Douglas et al., 2003
8 40/M Abscess PT brain abscess 16S rDNA Kupila et al., 2006
9 48/M CSF, bone graft PO brain abscess 16S rDNA
Culture
McCarthy and Looke, 2008
10 17/F Abscess, soft tissues PO brain abscess Culture McCarthy and Looke, 2008
11 41/F Abscess Post abortion brain abscess 16S rRNA Al Masalma et al., 2011
12 48/F CSF PO brain abscess 16S rRNA
Culture
Lee et al., 2012
13 26/M CSF Meningitis (secondary to SA) 16S rDNA
Culture
Sato et al., 2012
14 40/M Abscess PT brain abscess 16S rDNA
Culture
Henao-Martı´nez et al., 2012




Pailhorie`s et al., 2014




Hos et al., 2015
17 39/M CSF PO meningitis Speciﬁc qPCR
Culture
This case, 2016
CSF, cerebrospinal ﬂuid; CNS, central nervous system; F, female; M, male; MALDI-TOF MS, matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry; PO,
postoperative; PP, post-partum; PT, post-traumatic; SA, septic arthritis.
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EVD was changed. Analysis of the CSF samples collected on days
16, 17, and 20 showed a decrease in the leukocyte count (2.3, 0.53,
and 0.33  109/l, respectively) and all bacterial cultures of CSF
samples remained sterile.
Follow-up imaging on day 21 showed moderate hydrocephaly
with ischemic areas in both territories of the ACA. Sedation of the
patient was then ended, and a neurological evaluation revealed
tetraparesis and varying responses to simple orders. A new EVD
was placed on day 22 to manage the hydrocephaly. CSF collected
during the procedure was still abnormal (0.74  109 leukocytes/l
with 94% neutrophils). At the same time, serological testing for
HIV, hepatitis C virus, and hepatitis B virus was done; all tests were
negative. Cytomegalovirus (CMV) serology in the CSF was positive
for IgG and IgM suggesting reactivation in the CSF. Mycological
cultures were all negative, including those for Cryptococcus. PCR of
CSF samples for mycobacterial infections, Mycoplasma pneumoniae,
Chlamydia pneumoniae, CMV, herpes simplex virus, varicella zoster
virus, and enterovirus were also negative. Nevertheless, due to the
presence of tiny microcolonies on blood agar plates, 16S rRNA gene
sequencing was performed directly from the colonies. The CSF
sample obtained on day 33 was positive for Mycoplasma hominis by
quantitative real-time PCR (yidC gene)16.
Selective agar for M. hominis (A7 Mycoplasma; bioMe´rieux,
Marcy l’Etoile, France) was used to culture a CSF sample and was
positive, showing the typical ‘fried egg’ colonies. An antibiogram
performed using a Mycofast RevolutioN kit (Elitech, Puteaux,
France) revealed sensitivity to clindamycin, tetracycline, levo-
ﬂoxacin, and moxiﬂoxacin and conﬁrmed intrinsic resistance to
erythromycin. All CSF samples from day 22 to day 34 were
recovered and cultured on speciﬁc agar plates for Mycoplasma
spp. All of these specimens were positive for M.
hominis. Interestingly, identiﬁcation by matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry (MALDI-
TOF MS) was not possible, even after acetonitrile extraction.
Once the diagnosis had been made, moxiﬂoxacin was added to
the other antibiotics from day 34 to day 49. Three days after
introducing the treatment, the patient’s neurological statusdeclined. Magnetic resonance imaging (MRI) performed the day
after showed cortical laminar necrosis associated with tetraven-
tricular hydrocephaly. Due to the lack of improvement, the
patient’s critical condition, and the severe irreversible lesions,
the ethics staff decided to limit further therapeutic procedures and
the patient died on day 80.
3. Discussion
M. hominis is found in the human urogenital tract with a
prevalence of approximately 15% and is mainly involved in
urogenital infections and neonatal infections. Nevertheless, the
pathogenicity of this species may be difﬁcult to assess because it is
often present as a commensal organism. Although rare, extra-
genital infections have been described, such as bone and joint
infections and CNS infections, especially in newborn infants and
immunocompromised patients. In adults, only 16 cases of CNS
infection have been described since 1950, with 13 cases of brain
abscesses and three cases of meningitis (two postoperative
infections and one secondary to septic arthritis)11–13,15
(Table 1). In all cases described, the patients presented contribut-
ing factors such as a head trauma, neurosurgery, or genitourinary
or delivery manipulations. In the case presented here, the patient
suffered a subarachnoid haemorrhage and had a urinary catheter,
two important comorbidities for CNS infections caused by M.
hominis.
The lack of bacterial cell wall components makes M. hominis
undetectable by Gram staining. Bacterial culture is very slow (2–5
days) and requires speciﬁc agar plates enriched with arginine. On
appropriate media, M. hominis produces typical fried egg shaped
colonies. Culture is the gold standard procedure for identiﬁcation,
nevertheless only a few microbiology laboratories have used
speciﬁc agar for M. hominis in meningitis cases. Blood culture
systems appear to be ineffective for the detection of M.
hominis. Studies have reported identiﬁcation using MALDI-TOF
MS,14 and molecular techniques such as 16S rRNA gene sequencing
and real-time PCR.11,16 In the case reported here, identiﬁcation of
M. hominis was performed using TaqMan quantitative real-time
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(Microﬂex; Bruker, Bremen, Germany) failed to identify M.
hominis. It is assumed that growth on blood agar plates does not
allow identiﬁcation, because all previous cases that were identiﬁed
by MALDI-TOF MS reported growth on speciﬁc agar, such as PPLO
medium and Hayﬂick arginine medium.14 Moreover, M. hominis
spectra used for MALDI-TOF identiﬁcation were not available in the
initial Bruker software library.
M. hominis is intrinsically resistant to a variety of antibiotic
classes such as b-lactams, glycopeptides, fosfomycin, sulfona-
mides, and macrolides. The major antibiotics active against M.
hominis are the tetracyclines, lincosamides, chloramphenicol, and
ﬂuoroquinolones. In the case presented here, an antibiogram was
performed and revealed susceptibility to clindamycin, tetracycline,
levoﬂoxacin, and moxiﬂoxacin. As M. hominis CNS infections may
result in aseptic lymphocytic meningitis syndrome, which is
treated empirically with antibiotics active on the bacterial cell wall
such as third-generation cephalosporins, the change to appropriate
targeted therapeutic management could be delayed signiﬁcantly.
In this case, the patient received appropriate antibiotherapy
24 days after the onset of symptoms. Fluoroquinolones (e.g.,
moxiﬂoxacin and levoﬂoxacin) have been described as providing
effective therapy with signiﬁcant CNS penetration,9,11 and the side
effects are less signiﬁcant compared to those of other effective
therapeutics such as chloramphenicol or cyclins.
In conclusion, this case of M. hominis meningitis shows that
empirical antibiotic treatment for nosocomial aseptic meningitis
has a high chance of failure and that the new technique of real-time
PCR appears to be more effective and faster than routine bacterial
culture. Despite the death of this patient, moxiﬂoxacin could be
considered effective against M. hominis, as has been described
previously in other studies. M. hominis should be considered as a
causative agent of CNS infection after neurosurgical procedures,
especially if there is no rapid response to antimicrobial therapy and
routine culture of CSF samples remains negative.
Conﬂict of interest: The authors declare that they have no conﬂict
of interest.References
1. Paine Jr TJ, Murray R, Perlmutter I, Finland M. Brain abscess and meningitis
associated with pleuropneumonia-like organism: clinical and bacteriological
observations in a case with recovery. Ann Intern Med 1950;32:554–62.
2. Payan DG, Seigal N, Madoff S. Infection of a brain abscess of Mycoplasma
hominis. J Clin Microbiol 1981;14:571–3.
3. McMahon DK, Dummer JS, Pasculle AW, Cassell G. Extragenital Mycoplasma
hominis infections in adults. Am J Med 1990;89:275–81.
4. Cohen M, Kubak B. Mycoplasma hominis meningitis complicating head trauma:
case report and review. Clin Infect Dis 1997;24:272–3.
5. Zheng X, Olson DA, Tully JG, Watson HL, Cassell GH, Gustafson DR, et al.
Isolation of Mycoplasma hominis from a brain abscess. J Clin Microbiol
1997;35:992–4.
6. House P, Dunn J, Carroll K, MacDonald J. Seeding of a cavernous angioma with
Mycoplasma hominis: case report. Neurosurgery 2003;53:749–52. discussion
752–7.
7. Douglas MW, Fisher DA, Lum GD, Roy J. Mycoplasma hominis infection of a
subdural haematoma in the peripartum period. Pathology (Phila) 2003;35:
452–4.
8. Kupila L, Rantakokko-Jalava K, Jalava J, Peltonen R, Marttila RJ, Kotilainen E, et al.
Brain abscess caused by Mycoplasma hominis: a clinically recognizable entity?
Eur J Neurol 2006;13:550–1.
9. McCarthy KL, Looke DF. Successful treatment of post-neurosurgical intracranial
Mycoplasma hominis infection using gatiﬂoxacin. J Infect 2008;57:344–6.
10. Al Masalma M, Drancourt M, Dufour H, Raoult D, Fournier PE. Mycoplasma
hominis brain abscess following uterus curettage: a case report. J Med Case Rep
2011;5:278.
11. Lee EH, Winter HL, van Dijl JM, Metzemaekers JD, Arends JP. Diagnosis and
antimicrobial therapy of Mycoplasma hominis meningitis in adults. Int J Med
Microbiol 2012;302:289–92.
12. Sato H, Iino N, Ohashi R, Saeki T, Ito T, Saito M, et al. Hypogammaglobu-
linemic patient with polyarthritis mimicking rheumatoid arthritis ﬁnally
diagnosed as septic arthritis caused by Mycoplasma hominis. Intern Med
2012;51:425–9.
13. Henao-Martı´nez AF, Young H, Nardi-Korver JJ, Burman W. Mycoplasma hominis
brain abscess presenting after a head trauma: a case report. J Med Case Rep
2012;6:253.
14. Pailhorie`s H, Rabier V, Eveillard M, Mahaza C, Joly-Guillou ML, Chennebault JM,
et al. A case report of Mycoplasma hominis brain abscess identiﬁed by MALDI-
TOF mass spectrometry. Int J Infect Dis 2014;29:166–8.
15. Hos NJ, Bauer C, Liebig T, Plum G, Seifert H, Hampl J. Autoinfection as a cause of
postpartum subdural empyema due to Mycoplasma hominis. Infection 2015;43:
241–4.
16. Fe´randon C, Peuchant O, Janis C, Benard A, Renaudin H, Pereyre S, et al.
Development of a real-time PCR targeting the yidC gene for the detection of
Mycoplasma hominis and comparison with quantitative culture. Clin Microbiol
Infect 2011;17:155–9.
